More intelligence articles

A snapshot of Congenica

PME talks to CEO David Atkins

Tackling antimicrobial resistance on multiple fronts

An urgent change of direction is needed in how we respond to AMR

The changing nature of approvals – what does the future hold?

The 2019 CMR International Pharmaceutical R&D Factbook

Integrating electronic health records into clinical trials

How organisations are working to realise the research potential of EHRs

Keeping up the fight against HIV and using the lessons to tackle other threats

Danny Buckland interviews Gilead’s Mike Elliott

Can marketing change the world?

Chris Ross explores the ability of creative communications to change minds and habits

Driving the innovation engine

Why open innovation is so important and the benefits it brings

The mission matters

The mission statement is more than a platitude

The transatlantic opioid crisis

Could the scale of litigation against so-called ‘Opioid Inc’ reach the heights of those pursued against Big Tobacco?

A snapshot of Healx

PME talks to CSO Neil Thompson

Entrepreneurial Winning Women

An executive education programme that supports women founders who have built profitable small companies

Novel endpoints in the digital age

Redesigning the goalposts

The 2019 CPhI Pharma Index Report

Examining this year’s industry performance

As the opioid crisis grabs the headlines, the search for safe treatments continues

Indivior’s Gilles Picard charts a path to greater patient access and new therapies

Creativity in storytelling: why pharma must invest more in creativity

Chris Ross explores the value, the art and the much-rumoured death of creativity